KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Assets (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Current Assets for 13 consecutive years, with $63.6 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 90.63% to $63.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.6 million through Dec 2025, up 90.63% year-over-year, with the annual reading at $63.6 million for FY2025, 90.63% up from the prior year.
  • Current Assets hit $63.6 million in Q4 2025 for ClearPoint Neuro, up from $51.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $70.4 million in Q1 2021 to a low of $24.2 million in Q1 2025.
  • Historically, Current Assets has averaged $50.0 million across 5 years, with a median of $51.3 million in 2022.
  • Biggest five-year swings in Current Assets: surged 222.85% in 2021 and later plummeted 49.1% in 2025.
  • Year by year, Current Assets stood at $61.9 million in 2021, then decreased by 17.31% to $51.2 million in 2022, then decreased by 29.32% to $36.2 million in 2023, then dropped by 7.77% to $33.4 million in 2024, then surged by 90.63% to $63.6 million in 2025.
  • Business Quant data shows Current Assets for CLPT at $63.6 million in Q4 2025, $51.3 million in Q3 2025, and $54.0 million in Q2 2025.